Tailwind Biotech ApS: Financial statements 2025
CVR: 43630938
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Tailwind Biotech ApS (CVR 43630938) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 636,591 and a net result of DKK -41,518 compared with DKK -26,662 the year before. That is a decrease of 25.3% compared with the year before. Equity in the 2025 report amounted to DKK -32,297.
- Gross Profit
- DKK 636,591
- Profit/Loss
- DKK -41,518
- Equity
- DKK -32,297
- Total Assets
- DKK 23,820
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 637 t. | -42 t. | -32 t. | 0 |
| 2024 | - | 853 t. | -27 t. | 9 t. | 3 |
Official annual report
How creditworthy is Tailwind Biotech ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Tailwind Biotech ApS has published its annual report for 2024. Gross profit came to DKK 852,654, and the net result was DKK -26,662.
About Tailwind Biotech ApS
Tailwind Biotech ApS is a Danish company of the type Anpartsselskab based in Taastrup, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Christopher Thomas Workman, Lorenzo Carvelli and Mirko Ceriani. The company's owners include HT Simonsen Holding ApS, CTW Holding ApS and LCAR Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 636,591 and a net result of DKK -41,518 compared with DKK -26,662 the year before. Equity in the 2025 report amounted to DKK -32,297.